SUBSCRIBE
SUBSCRIBE

China

Pictured: 3D rendering of antibody-drug conjugate/
Business
Biotheus, Hansoh Expand Partnership in $694M ADC Deal
The Chinese biotechs are broadening their collaboration. Hansoh Pharma is licensing Biotheus’ anti-EGFR/cMet bispecific antibody to develop antibody-drug conjugates.
March 15, 2024
 · 
2 min read
 · 
Tyler Patchen
Load More
PRESS RELEASES
Press Releases
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement
May 7, 2025
 · 
6 min read
Press Releases
Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema
May 7, 2025
 · 
9 min read
Press Releases
CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR
May 7, 2025
 · 
10 min read
Press Releases
Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial
May 6, 2025
 · 
2 min read
Press Releases
CStone Presents the Latest Preclinical Findings of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) at 2025 AACR
May 6, 2025
 · 
5 min read
Press Releases
Innovent Announces Oral Presentation of Full Phase 2 Clinical Data for Efdamrofusp Alfa (IBI302), First-in-class anti-VEGF/complement Bispecific Fusion Protein at ARVO 2025
May 6, 2025
 · 
7 min read
Press Releases
IND Application for NTS071, Nutshell Therapeutics’ p53 Y220C Allosteric Reactivator, Received US FDA clearance
May 5, 2025
 · 
3 min read
Press Releases
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
May 2, 2025
 · 
5 min read
Press Releases
Eccogene Appoints Dr. Jai Patel as Chief Medical Officer
May 2, 2025
 · 
2 min read
Press Releases
InnoCare’s Zurletrectinib Receives Priority Review from China’s NMPA
May 2, 2025
 · 
2 min read
Press Releases
JediCare Medical has announced successful completion of its first-in-human feasibility study of the world’s first-of-its-kind Pulmonary Nodule Percutaneous Sphere Resection
May 1, 2025
 · 
6 min read
Press Releases
Genocury Biotech Announces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy
May 1, 2025
 · 
4 min read
Press Releases
Mabwell Releases 6 Study Results of Innovative Drugs and Platforms at the 2025 AACR Annual Meeting
April 30, 2025
 · 
8 min read
Press Releases
Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy
April 30, 2025
 · 
4 min read
Press Releases
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
April 30, 2025
 · 
2 min read
Press Releases
Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies
April 30, 2025
 · 
6 min read
Press Releases
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
April 29, 2025
 · 
3 min read
Press Releases
Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE
April 28, 2025
 · 
2 min read
Press Releases
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
April 28, 2025
 · 
7 min read
Press Releases
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
April 28, 2025
 · 
8 min read
Load More